Prospective Randomized Open-label Comparative Study of the Use of Intranasal Form of Interferon Gamma Human Recombinant in Patients for the Prevention of Acute Respiratory Viral Infections, Including COVID-19
Latest Information Update: 12 Aug 2024
At a glance
- Drugs Interferon gamma (Primary)
- Indications COVID-19 respiratory infection
- Focus Therapeutic Use
- Sponsors Pharmaclon
- 29 Sep 2021 New trial record